Free Trial

Alpha Teknova (TKNO) Competitors

Alpha Teknova logo
$7.74 +1.53 (+24.64%)
(As of 11/20/2024 ET)

TKNO vs. OSUR, SERA, AXDX, CODX, NTUS, KURA, MESO, GYRE, RCKT, and CALT

Should you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include OraSure Technologies (OSUR), Sera Prognostics (SERA), Accelerate Diagnostics (AXDX), Co-Diagnostics (CODX), Natus Medical (NTUS), Kura Oncology (KURA), Mesoblast (MESO), Gyre Therapeutics (GYRE), Rocket Pharmaceuticals (RCKT), and Calliditas Therapeutics AB (publ) (CALT). These companies are all part of the "medical" sector.

Alpha Teknova vs.

Alpha Teknova (NASDAQ:TKNO) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

OraSure Technologies received 542 more outperform votes than Alpha Teknova when rated by MarketBeat users. Likewise, 69.53% of users gave OraSure Technologies an outperform vote while only 36.36% of users gave Alpha Teknova an outperform vote.

CompanyUnderperformOutperform
Alpha TeknovaOutperform Votes
8
36.36%
Underperform Votes
14
63.64%
OraSure TechnologiesOutperform Votes
550
69.53%
Underperform Votes
241
30.47%

OraSure Technologies has a net margin of 5.07% compared to Alpha Teknova's net margin of -87.17%. OraSure Technologies' return on equity of 3.55% beat Alpha Teknova's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Teknova-87.17% -35.30% -24.52%
OraSure Technologies 5.07%3.55%3.23%

Alpha Teknova currently has a consensus target price of $5.00, indicating a potential downside of 35.40%. OraSure Technologies has a consensus target price of $6.67, indicating a potential upside of 74.98%. Given OraSure Technologies' higher possible upside, analysts plainly believe OraSure Technologies is more favorable than Alpha Teknova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Teknova
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
OraSure Technologies
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

13.8% of Alpha Teknova shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 15.2% of Alpha Teknova shares are owned by company insiders. Comparatively, 3.4% of OraSure Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Alpha Teknova has a beta of 0.35, indicating that its share price is 65% less volatile than the S&P 500. Comparatively, OraSure Technologies has a beta of 0.05, indicating that its share price is 95% less volatile than the S&P 500.

OraSure Technologies has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Teknova$36.68M11.25-$36.78M-$0.74-10.46
OraSure Technologies$405.47M0.70$53.65M$0.1525.40

In the previous week, OraSure Technologies had 2 more articles in the media than Alpha Teknova. MarketBeat recorded 2 mentions for OraSure Technologies and 0 mentions for Alpha Teknova. OraSure Technologies' average media sentiment score of 0.44 beat Alpha Teknova's score of 0.00 indicating that OraSure Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Teknova Neutral
OraSure Technologies Neutral

Summary

OraSure Technologies beats Alpha Teknova on 13 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TKNO vs. The Competition

MetricAlpha TeknovaDiagnostic substances IndustryMedical SectorNASDAQ Exchange
Market Cap$331.04M$2.20B$5.06B$8.89B
Dividend YieldN/A0.75%4.97%4.06%
P/E Ratio-10.462.6189.0213.30
Price / Sales11.2541.431,207.2881.01
Price / CashN/A14.8239.1736.03
Price / Book4.723.116.085.74
Net Income-$36.78M$29.98M$119.07M$225.93M
7 Day Performance17.99%-1.26%-1.84%-1.32%
1 Month Performance16.92%-9.92%-3.65%0.60%
1 Year Performance256.68%-14.62%31.62%26.23%

Alpha Teknova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TKNO
Alpha Teknova
0.7174 of 5 stars
$7.74
+24.6%
$5.00
-35.4%
+279.4%$331.04M$36.68M-10.46240Gap Up
High Trading Volume
OSUR
OraSure Technologies
4.4944 of 5 stars
$3.81
-1.3%
$6.67
+75.0%
-47.2%$287.93M$405.47M25.40638
SERA
Sera Prognostics
1.0508 of 5 stars
$6.03
-2.4%
N/A+235.0%$208.71M$310,000.000.00120
AXDX
Accelerate Diagnostics
2.4379 of 5 stars
$1.70
-2.9%
$1.00
-41.2%
-67.0%$43.83M$12.06M0.00134
CODX
Co-Diagnostics
4.3727 of 5 stars
$1.04
-2.8%
$1.50
+44.2%
-27.8%$34.17M$6.81M0.00100Short Interest ↓
Gap Down
NTUS
Natus Medical
N/A$32.96
flat
N/A+0.0%$1.14B$473.44M89.081,400Analyst Forecast
KURA
Kura Oncology
4.082 of 5 stars
$15.91
-0.3%
$28.83
+81.2%
+66.6%$1.24BN/A-6.74142Analyst Forecast
News Coverage
MESO
Mesoblast
1.3555 of 5 stars
$10.33
-4.5%
$11.50
+11.3%
+345.3%$1.24B$5.90M0.0080Gap Down
GYRE
Gyre Therapeutics
0.4926 of 5 stars
$12.91
-0.1%
N/A-12.1%$1.21B$113.45M0.0040
RCKT
Rocket Pharmaceuticals
4.4174 of 5 stars
$13.04
-0.9%
$51.00
+291.1%
-40.8%$1.20BN/A-4.74240Analyst Forecast
Analyst Revision
CALT
Calliditas Therapeutics AB (publ)
0.2583 of 5 stars
$40.00
flat
$39.25
-1.9%
N/A$1.19B$1.60B-21.62180Positive News

Related Companies and Tools


This page (NASDAQ:TKNO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners